Coloplast A/S (COLO-B.CO)

Exchange: Copenhagen Exchange
Currency: DKK

Price: 994.80 (Close)



52 Week range 200d Moving Avg. Beta
883.60 – 1,194.00 1,052.76 0.15
Dividend Dividend Yield Ex-Dividend date
19.00 1.91% 2021-12-03
P/E Ratio Latest EPS DGR 3 years
43.33 22.96 5.90%
Very low Volatility
Dividend Growth


Coloplast A/S develops and markets intimate healthcare products and services worldwide. The company operates through three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit to individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as SpeediCath catheters that offer catherisation for both genders; Peristeen, an anal irrigation system for controlled emptying of the bowels; and Conveen Active urine bags. In addition, it provides wound care products, such as foam dressings under the Biatain brand and hydrocolloid dressing under the Comfeel brand, as well as skin care products, such as bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. It offers disposable products that include prostate catheters and stents used before, during, and after surgery under the Porgès brand; vaginal slings to restore continence; synthetic mesh products to treat weak pelvic floor; and penile implants for men. The company supplies its products to hospitals, institutions, wholesalers, and pharmacies; and directly to users. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.


Sector: Industry:
Healthcare Medical Instruments & Supplies

Environment, Social and Governance (ESG) Ratings

Total ESG Score

10 – 4 percentile


1 – 1 percentile


2 – 1 percentile


3 – 1 percentile

Controversy level



see MSCI ESG rating explained

Dividend Safety Metrics

Latest EPS 22.96
Annual Payout 19.00
Payout Ratio 82.75%
Dividend growth 21 Years
Dividend Score 61
Dividend Coverage Ratio 1.21
Altman-Z score 0.00


Coloplast A/S (COLO-B.CO) Valuation

Coloplast A/S current dividend yield of 1.91% is -16% below its 5-year average. The 5-year average dividend yield is 2.27% (see red-line in chart). This indicates the stock looks overvalued today.

Coloplast A/S (COLO-B.CO) Performance

The chart below displays the total price return(%) of Coloplast A/S for different periods:


Coloplast A/S (COLO-B.CO) Total Return

The chart below displays the (CAGR) total return (%) including all dividends paid of Coloplast A/S for different periods:


Dividend Scorecard

Dividend Yield (TTM) Annual Payout Payout Ratio Dividend growth
1.91 19.00 82.75% 21 Years


Dividend Growth Summary

3 Year Growth Rate (CAGR) 5.90%
5 Year Growth Rate (CAGR) 7.07%
10 Year Growth Rate (CAGR) 21.10%

Dividend Growth Rates History

Year Payout Amount Annual Payout Growth (YoY)
2021 19.000 5.6%
2020 18.000 5.9%
2019 17.000 6.3%
2018 16.000 6.7%
2017 15.000 11.1%
2016 13.500 8.0%
2015 12.500 4.2%
2014 12.000 49.3%
2013 8.040 101.0%
2012 4.000 42.9%
2011 2.800 40.0%
2010 2.000 42.9%
2009 1.400 16.7%
2008 1.200 -33.3%

Coloplast A/S (COLO-B.CO) Dividend Payment History